UPDATE ON OBESITY AND CARDIOVASCULAR RISK: FROM PATHOPHYSIOLOGY TO CLINICAL MANAGEMENT

Descargar Publicación
Nuevas moléculas del IOCB de Praga reducen el apetito y protegen el cerebro contra enfermedades de tipo Alzheimer Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study